: Many analysts, including those from Barclays and Goldman Sachs , see the current price (near its 52-week low of ~$59) as an attractive entry point with predicted upsides ranging from 37% to over 50%.
: Management announced a $2 billion share repurchase program for Q2, signaling confidence in the stock's long-term value. bsx stock buy or sell
: Despite trimming price targets, the consensus remains a Moderate Buy . : Many analysts, including those from Barclays and
: Fresh data from the Heart Rhythm 2026 conference continues to support the safety and efficacy of key franchises like FARAPULSE and WATCHMAN . The Sell Case: Rising Risks : Many analysts